Cargando…

Investigating pharmacological mechanisms of andrographolide on non-alcoholic steatohepatitis (NASH): A bioinformatics approach of network pharmacology

OBJECTIVE: To investigate the mechanisms of andrographolide against non-alcoholic steatohepatitis (NASH) based on network pharmacology, so as to provide a reference for further study of andrographolide in the treatment of NASH and other metabolic diseases. METHODS: The methionine- and choline-defici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lei, Li, Sheng-he, Jiang, Jin-peng, Liu, Chang, Ji, Li-li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476713/ https://www.ncbi.nlm.nih.gov/pubmed/36118934 http://dx.doi.org/10.1016/j.chmed.2021.05.001

Ejemplares similares

Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation
por: Wu, Xia, et al.
Publicado: (2023)

Andrographolide in atherosclerosis: integrating network pharmacology and in vitro pharmacological evaluation
por: Shi, Shuai, et al.
Publicado: (2022)

Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking
por: Gao, Rui, et al.
Publicado: (2022)

Network Pharmacology Analysis and Experimental Validation to Explore the Anti-inflammatory Mechanism of Asiatic Acid on Alcoholic Steatohepatitis
por: Jiang, Tao, et al.
Publicado: (2022)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2014)

Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking
por: Yadav, Ravi Prakash, et al.
Publicado: (2022)

Andrographolide Against Lung Cancer-New Pharmacological Insights Based on High-Throughput Metabolomics Analysis Combined with Network Pharmacology
por: Luo, Wen, et al.
Publicado: (2021)

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
por: Li, Xinzhi, et al.
Publicado: (2022)

Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment
por: Ilan, Yaron
Publicado: (2018)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
por: Lee, Jin Ha, et al.
Publicado: (2020)

Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
por: Suri, Jaspreet, et al.
Publicado: (2022)

A bioinformatics investigation into the pharmacological mechanisms of the effect of Fufang Danshen on pain based on methodologies of network pharmacology
por: Sun, Yantao, et al.
Publicado: (2019)

A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology
por: Zhang, Jingyuan, et al.
Publicado: (2020)

Deciphering the Effective Constituents and Mechanisms of Portulaca oleracea L. for Treating NASH via Integrating Bioinformatics Analysis and Experimental Pharmacology
por: He, Xiaoli, et al.
Publicado: (2022)

A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer
por: Janani, Balakarthikeyan, et al.
Publicado: (2022)

Anti-Autophagy Mechanism of Zhi Gan Prescription Based on Network Pharmacology in Nonalcoholic Steatohepatitis Rats
por: Qin, Chufeng, et al.
Publicado: (2021)

The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2016)

Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
por: Sharma, Mithun, et al.
Publicado: (2021)

Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma
por: Ma, Chongyang, et al.
Publicado: (2019)

State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
por: Cho, Yongin, et al.
Publicado: (2022)

Mechanism of Salvia miltiorrhiza Bge. for the Treatment of Ischemic Stroke Based on Bioinformatics and Network Pharmacology
por: Wu, Jiaqi, et al.
Publicado: (2022)

Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Zao-Jiao-Ci in the Treatment of LSCC
por: Xiang, Feng, et al.
Publicado: (2021)

Development of a Bifunctional Andrographolide-Based Chemical Probe for Pharmacological Study
por: Hsu, Ya-Hsin, et al.
Publicado: (2016)

Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of Aloe vera for Non-Alcoholic Steatohepatitis Treatment
por: Nguyen, Tan Khanh, et al.
Publicado: (2022)

Network Pharmacology and Bioinformatics Approach Reveals the Multi-Target Pharmacological Mechanism of Fumaria indica in the Treatment of Liver Cancer
por: Batool, Sara, et al.
Publicado: (2022)

Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model
por: TORINIWA, Yasufumi, et al.
Publicado: (2018)

Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients
por: Losekann, Alexandre, et al.
Publicado: (2015)

Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)
por: Min-DeBartolo, Jessica, et al.
Publicado: (2019)

Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
por: dos Santos, João Paulo Margiotti, et al.
Publicado: (2022)

A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)
por: Sekhon, Anupamjeet Kaur, et al.
Publicado: (2021)

Current and future pharmacological therapies for NAFLD/NASH
por: Sumida, Yoshio, et al.
Publicado: (2017)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Cabrera, Daniel, et al.
Publicado: (2017)

Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis
por: Li, Jian, et al.
Publicado: (2015)

Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH)
por: Kaur, Savneet, et al.
Publicado: (2019)

A bioinformatics investigation into the pharmacological mechanisms of javanica oil emulsion injection in non-small cell lung cancer based on network pharmacology methodologies
por: Ni, Mengwei, et al.
Publicado: (2020)

A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network Pharmacology
por: Mai, Ziling, et al.
Publicado: (2021)

Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea
por: Zhang, Huaxiong, et al.
Publicado: (2021)

Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification
por: Zhi, Guoguo, et al.
Publicado: (2023)

Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
por: Yu, Guohua, et al.
Publicado: (2018)

Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tuagklidtm6pn43305q9tpgl01